WuXi Biologics (Cayman) Inc.
WuXi Biologics (Cayman) Inc. WXIBF Peers
See (WXIBF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| WXIBF | $3.20 | +6.67% | 13B | 29.09 | $0.11 | N/A |
| NONOF | $71.25 | +1.05% | 307.3B | 20.18 | $3.53 | +2.37% |
| CSLLY | $79.58 | -1.75% | 154.1B | 29.26 | $2.72 | +1.67% |
| CMXHF | $164.94 | +1.70% | 79.9B | 30.26 | $5.45 | +1.68% |
| BBIXF | $0.05 | +50900.00% | 38.8B | -5.10 | -$0.01 | N/A |
| UCBJY | $90.55 | -2.72% | 34.4B | 29.40 | $3.08 | +0.87% |
| ARGNF | $562.00 | N/A | 34.3B | 34.25 | $16.41 | N/A |
| UCBJF | $179.39 | +2.07% | 34.1B | 29.17 | $6.15 | +0.91% |
| ODTC | $22,005.00 | +29.44% | 24.1B | -0.08 | -$268,995.00 | N/A |
| IVBXF | $8.25 | +5.68% | 13.6B | -825.00 | -$0.01 | N/A |
Stock Comparison
WXIBF vs NONOF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, NONOF has a market cap of 307.3B. Regarding current trading prices, WXIBF is priced at $3.20, while NONOF trades at $71.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas NONOF's P/E ratio is 20.18. In terms of profitability, WXIBF's ROE is +0.06%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, WXIBF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs CSLLY Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, CSLLY has a market cap of 154.1B. Regarding current trading prices, WXIBF is priced at $3.20, while CSLLY trades at $79.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas CSLLY's P/E ratio is 29.26. In terms of profitability, WXIBF's ROE is +0.06%, compared to CSLLY's ROE of +0.15%. Regarding short-term risk, WXIBF is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs CMXHF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, CMXHF has a market cap of 79.9B. Regarding current trading prices, WXIBF is priced at $3.20, while CMXHF trades at $164.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas CMXHF's P/E ratio is 30.26. In terms of profitability, WXIBF's ROE is +0.06%, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, WXIBF is less volatile compared to CMXHF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs BBIXF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, BBIXF has a market cap of 38.8B. Regarding current trading prices, WXIBF is priced at $3.20, while BBIXF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas BBIXF's P/E ratio is -5.10. In terms of profitability, WXIBF's ROE is +0.06%, compared to BBIXF's ROE of -2.10%. Regarding short-term risk, WXIBF is less volatile compared to BBIXF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs UCBJY Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, UCBJY has a market cap of 34.4B. Regarding current trading prices, WXIBF is priced at $3.20, while UCBJY trades at $90.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas UCBJY's P/E ratio is 29.40. In terms of profitability, WXIBF's ROE is +0.06%, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, WXIBF is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs ARGNF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, ARGNF has a market cap of 34.3B. Regarding current trading prices, WXIBF is priced at $3.20, while ARGNF trades at $562.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas ARGNF's P/E ratio is 34.25. In terms of profitability, WXIBF's ROE is +0.06%, compared to ARGNF's ROE of +0.16%. Regarding short-term risk, WXIBF and ARGNF have similar daily volatility (0.00).
WXIBF vs UCBJF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, UCBJF has a market cap of 34.1B. Regarding current trading prices, WXIBF is priced at $3.20, while UCBJF trades at $179.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas UCBJF's P/E ratio is 29.17. In terms of profitability, WXIBF's ROE is +0.06%, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, WXIBF and UCBJF have similar daily volatility (0.00).
WXIBF vs ODTC Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, ODTC has a market cap of 24.1B. Regarding current trading prices, WXIBF is priced at $3.20, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas ODTC's P/E ratio is -0.08. In terms of profitability, WXIBF's ROE is +0.06%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, WXIBF and ODTC have similar daily volatility (0.00).
WXIBF vs IVBXF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, IVBXF has a market cap of 13.6B. Regarding current trading prices, WXIBF is priced at $3.20, while IVBXF trades at $8.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas IVBXF's P/E ratio is -825.00. In terms of profitability, WXIBF's ROE is +0.06%, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, WXIBF is less volatile compared to IVBXF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs GNMSF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, GNMSF has a market cap of 13B. Regarding current trading prices, WXIBF is priced at $3.20, while GNMSF trades at $212.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas GNMSF's P/E ratio is 12.44. In terms of profitability, WXIBF's ROE is +0.06%, compared to GNMSF's ROE of +0.26%. Regarding short-term risk, WXIBF is less volatile compared to GNMSF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs WXXWY Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, WXXWY has a market cap of 12.9B. Regarding current trading prices, WXIBF is priced at $3.20, while WXXWY trades at $6.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas WXXWY's P/E ratio is 28.45. In terms of profitability, WXIBF's ROE is +0.06%, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, WXIBF is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs SBMFF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, SBMFF has a market cap of 10.2B. Regarding current trading prices, WXIBF is priced at $3.20, while SBMFF trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas SBMFF's P/E ratio is 57.20. In terms of profitability, WXIBF's ROE is +0.06%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, WXIBF and SBMFF have similar daily volatility (0.00).
WXIBF vs SBHMY Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, SBHMY has a market cap of 8.7B. Regarding current trading prices, WXIBF is priced at $3.20, while SBHMY trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas SBHMY's P/E ratio is 33.62. In terms of profitability, WXIBF's ROE is +0.06%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, WXIBF and SBHMY have similar daily volatility (0.00).
WXIBF vs TRSBF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, TRSBF has a market cap of 6.1B. Regarding current trading prices, WXIBF is priced at $3.20, while TRSBF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas TRSBF's P/E ratio is 21.67. In terms of profitability, WXIBF's ROE is +0.06%, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, WXIBF and TRSBF have similar daily volatility (0.00).
WXIBF vs TLPPF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, TLPPF has a market cap of 5.6B. Regarding current trading prices, WXIBF is priced at $3.20, while TLPPF trades at $16.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas TLPPF's P/E ratio is 183.67. In terms of profitability, WXIBF's ROE is +0.06%, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, WXIBF and TLPPF have similar daily volatility (0.00).
WXIBF vs ABCZF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, WXIBF is priced at $3.20, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, WXIBF's ROE is +0.06%, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, WXIBF and ABCZF have similar daily volatility (0.00).
WXIBF vs ZLDPF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, ZLDPF has a market cap of 5B. Regarding current trading prices, WXIBF is priced at $3.20, while ZLDPF trades at $70.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas ZLDPF's P/E ratio is -27.06. In terms of profitability, WXIBF's ROE is +0.06%, compared to ZLDPF's ROE of -0.13%. Regarding short-term risk, WXIBF is less volatile compared to ZLDPF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs INCPF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, INCPF has a market cap of 4.9B. Regarding current trading prices, WXIBF is priced at $3.20, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas INCPF's P/E ratio is -108.67. In terms of profitability, WXIBF's ROE is +0.06%, compared to INCPF's ROE of -0.05%. Regarding short-term risk, WXIBF and INCPF have similar daily volatility (0.00).
WXIBF vs AKBLF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, AKBLF has a market cap of 4.8B. Regarding current trading prices, WXIBF is priced at $3.20, while AKBLF trades at $21.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas AKBLF's P/E ratio is 33.36. In terms of profitability, WXIBF's ROE is +0.06%, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, WXIBF is less volatile compared to AKBLF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs LABFF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, WXIBF is priced at $3.20, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas LABFF's P/E ratio is 28.95. In terms of profitability, WXIBF's ROE is +0.06%, compared to LABFF's ROE of +0.39%. Regarding short-term risk, WXIBF and LABFF have similar daily volatility (0.00).
WXIBF vs REGMF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, REGMF has a market cap of 3.4B. Regarding current trading prices, WXIBF is priced at $3.20, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas REGMF's P/E ratio is -13.32. In terms of profitability, WXIBF's ROE is +0.06%, compared to REGMF's ROE of -0.48%. Regarding short-term risk, WXIBF is less volatile compared to REGMF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs CAMRF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, CAMRF has a market cap of 3.3B. Regarding current trading prices, WXIBF is priced at $3.20, while CAMRF trades at $56.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas CAMRF's P/E ratio is 59.53. In terms of profitability, WXIBF's ROE is +0.06%, compared to CAMRF's ROE of +0.14%. Regarding short-term risk, WXIBF and CAMRF have similar daily volatility (0.00).
WXIBF vs GLPGF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, GLPGF has a market cap of 3.2B. Regarding current trading prices, WXIBF is priced at $3.20, while GLPGF trades at $48.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas GLPGF's P/E ratio is -15.86. In terms of profitability, WXIBF's ROE is +0.06%, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, WXIBF is less volatile compared to GLPGF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs TKBIF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, TKBIF has a market cap of 2.8B. Regarding current trading prices, WXIBF is priced at $3.20, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, WXIBF's ROE is +0.06%, compared to TKBIF's ROE of N/A. Regarding short-term risk, WXIBF and TKBIF have similar daily volatility (0.00).
WXIBF vs GNNSF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, GNNSF has a market cap of 2.8B. Regarding current trading prices, WXIBF is priced at $3.20, while GNNSF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas GNNSF's P/E ratio is -16.25. In terms of profitability, WXIBF's ROE is +0.06%, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, WXIBF and GNNSF have similar daily volatility (0.00).
WXIBF vs MPSYF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, WXIBF is priced at $3.20, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, WXIBF's ROE is +0.06%, compared to MPSYF's ROE of +2.51%. Regarding short-term risk, WXIBF is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs ASPHF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, ASPHF has a market cap of 2.2B. Regarding current trading prices, WXIBF is priced at $3.20, while ASPHF trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas ASPHF's P/E ratio is -35.83. In terms of profitability, WXIBF's ROE is +0.06%, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, WXIBF and ASPHF have similar daily volatility (0.00).
WXIBF vs SHJBF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, SHJBF has a market cap of 2.1B. Regarding current trading prices, WXIBF is priced at $3.20, while SHJBF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas SHJBF's P/E ratio is -7.22. In terms of profitability, WXIBF's ROE is +0.06%, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, WXIBF and SHJBF have similar daily volatility (0.00).
WXIBF vs BVNKF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, BVNKF has a market cap of 2.1B. Regarding current trading prices, WXIBF is priced at $3.20, while BVNKF trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas BVNKF's P/E ratio is 10.87. In terms of profitability, WXIBF's ROE is +0.06%, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, WXIBF is less volatile compared to BVNKF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs BVNRY Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, BVNRY has a market cap of 2.1B. Regarding current trading prices, WXIBF is priced at $3.20, while BVNRY trades at $9.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas BVNRY's P/E ratio is 10.83. In terms of profitability, WXIBF's ROE is +0.06%, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, WXIBF is less volatile compared to BVNRY. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs SYGGF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, SYGGF has a market cap of 2B. Regarding current trading prices, WXIBF is priced at $3.20, while SYGGF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas SYGGF's P/E ratio is -0.47. In terms of profitability, WXIBF's ROE is +0.06%, compared to SYGGF's ROE of -0.62%. Regarding short-term risk, WXIBF and SYGGF have similar daily volatility (0.00).
WXIBF vs BTTAY Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, BTTAY has a market cap of 1.9B. Regarding current trading prices, WXIBF is priced at $3.20, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas BTTAY's P/E ratio is -69.23. In terms of profitability, WXIBF's ROE is +0.06%, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, WXIBF is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs MEOBF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, MEOBF has a market cap of 1.8B. Regarding current trading prices, WXIBF is priced at $3.20, while MEOBF trades at $1.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas MEOBF's P/E ratio is -16.05. In terms of profitability, WXIBF's ROE is +0.06%, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, WXIBF and MEOBF have similar daily volatility (0.00).
WXIBF vs PHMMF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, PHMMF has a market cap of 1.8B. Regarding current trading prices, WXIBF is priced at $3.20, while PHMMF trades at $103.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas PHMMF's P/E ratio is 81.58. In terms of profitability, WXIBF's ROE is +0.06%, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, WXIBF and PHMMF have similar daily volatility (0.00).
WXIBF vs GENSF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, GENSF has a market cap of 1.7B. Regarding current trading prices, WXIBF is priced at $3.20, while GENSF trades at $26.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas GENSF's P/E ratio is -332.47. In terms of profitability, WXIBF's ROE is +0.06%, compared to GENSF's ROE of +0.01%. Regarding short-term risk, WXIBF and GENSF have similar daily volatility (0.00).
WXIBF vs BRCTF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, BRCTF has a market cap of 1.7B. Regarding current trading prices, WXIBF is priced at $3.20, while BRCTF trades at $18.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas BRCTF's P/E ratio is 17.85. In terms of profitability, WXIBF's ROE is +0.06%, compared to BRCTF's ROE of -0.19%. Regarding short-term risk, WXIBF and BRCTF have similar daily volatility (0.00).
WXIBF vs BIESF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, WXIBF is priced at $3.20, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas BIESF's P/E ratio is -45.07. In terms of profitability, WXIBF's ROE is +0.06%, compared to BIESF's ROE of +0.05%. Regarding short-term risk, WXIBF and BIESF have similar daily volatility (0.00).
WXIBF vs PPTDF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, PPTDF has a market cap of 1.5B. Regarding current trading prices, WXIBF is priced at $3.20, while PPTDF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas PPTDF's P/E ratio is 15.38. In terms of profitability, WXIBF's ROE is +0.06%, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, WXIBF and PPTDF have similar daily volatility (0.00).
WXIBF vs ONTTF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, ONTTF has a market cap of 1.5B. Regarding current trading prices, WXIBF is priced at $3.20, while ONTTF trades at $1.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas ONTTF's P/E ratio is -7.52. In terms of profitability, WXIBF's ROE is +0.06%, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, WXIBF is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs CSBTF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, CSBTF has a market cap of 1.1B. Regarding current trading prices, WXIBF is priced at $3.20, while CSBTF trades at $28.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas CSBTF's P/E ratio is -240.94. In terms of profitability, WXIBF's ROE is +0.06%, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, WXIBF is less volatile compared to CSBTF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs NURPF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, NURPF has a market cap of 1B. Regarding current trading prices, WXIBF is priced at $3.20, while NURPF trades at $8.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas NURPF's P/E ratio is 11.67. In terms of profitability, WXIBF's ROE is +0.06%, compared to NURPF's ROE of +0.49%. Regarding short-term risk, WXIBF is less volatile compared to NURPF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs ASCLF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, ASCLF has a market cap of 904M. Regarding current trading prices, WXIBF is priced at $3.20, while ASCLF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas ASCLF's P/E ratio is -23.31. In terms of profitability, WXIBF's ROE is +0.06%, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, WXIBF and ASCLF have similar daily volatility (0.00).
WXIBF vs PHGUF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, PHGUF has a market cap of 680.3M. Regarding current trading prices, WXIBF is priced at $3.20, while PHGUF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas PHGUF's P/E ratio is -50.00. In terms of profitability, WXIBF's ROE is +0.06%, compared to PHGUF's ROE of -0.06%. Regarding short-term risk, WXIBF and PHGUF have similar daily volatility (0.00).
WXIBF vs BPMUF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, BPMUF has a market cap of 636.6M. Regarding current trading prices, WXIBF is priced at $3.20, while BPMUF trades at $51.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas BPMUF's P/E ratio is 7.33. In terms of profitability, WXIBF's ROE is +0.06%, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, WXIBF is less volatile compared to BPMUF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs INRLF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, INRLF has a market cap of 552.7M. Regarding current trading prices, WXIBF is priced at $3.20, while INRLF trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas INRLF's P/E ratio is -5.16. In terms of profitability, WXIBF's ROE is +0.06%, compared to INRLF's ROE of -0.43%. Regarding short-term risk, WXIBF and INRLF have similar daily volatility (0.00).
WXIBF vs SOLTF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, SOLTF has a market cap of 534.2M. Regarding current trading prices, WXIBF is priced at $3.20, while SOLTF trades at $5.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas SOLTF's P/E ratio is -32.83. In terms of profitability, WXIBF's ROE is +0.06%, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, WXIBF is less volatile compared to SOLTF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs IVEVF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, IVEVF has a market cap of 506.3M. Regarding current trading prices, WXIBF is priced at $3.20, while IVEVF trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas IVEVF's P/E ratio is -1.05. In terms of profitability, WXIBF's ROE is +0.06%, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, WXIBF and IVEVF have similar daily volatility (0.00).
WXIBF vs CLTEF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, CLTEF has a market cap of 504.7M. Regarding current trading prices, WXIBF is priced at $3.20, while CLTEF trades at $7.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas CLTEF's P/E ratio is -7.06. In terms of profitability, WXIBF's ROE is +0.06%, compared to CLTEF's ROE of -0.43%. Regarding short-term risk, WXIBF and CLTEF have similar daily volatility (0.00).
WXIBF vs CKDXF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, CKDXF has a market cap of 475.6M. Regarding current trading prices, WXIBF is priced at $3.20, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, WXIBF's ROE is +0.06%, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, WXIBF is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs VBIZF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, VBIZF has a market cap of 472.2M. Regarding current trading prices, WXIBF is priced at $3.20, while VBIZF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas VBIZF's P/E ratio is 22.70. In terms of profitability, WXIBF's ROE is +0.06%, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, WXIBF and VBIZF have similar daily volatility (0.00).
WXIBF vs SNBIF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, SNBIF has a market cap of 471.7M. Regarding current trading prices, WXIBF is priced at $3.20, while SNBIF trades at $6.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas SNBIF's P/E ratio is -22.59. In terms of profitability, WXIBF's ROE is +0.06%, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, WXIBF is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs MDCLF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, MDCLF has a market cap of 463M. Regarding current trading prices, WXIBF is priced at $3.20, while MDCLF trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas MDCLF's P/E ratio is -10.45. In terms of profitability, WXIBF's ROE is +0.06%, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, WXIBF is less volatile compared to MDCLF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs AAVXF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, AAVXF has a market cap of 457.4M. Regarding current trading prices, WXIBF is priced at $3.20, while AAVXF trades at $7.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas AAVXF's P/E ratio is -2.27. In terms of profitability, WXIBF's ROE is +0.06%, compared to AAVXF's ROE of -1.10%. Regarding short-term risk, WXIBF and AAVXF have similar daily volatility (0.00).
WXIBF vs RAONF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, WXIBF is priced at $3.20, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas RAONF's P/E ratio is -43.33. In terms of profitability, WXIBF's ROE is +0.06%, compared to RAONF's ROE of -0.71%. Regarding short-term risk, WXIBF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs BXPHF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, BXPHF has a market cap of 451M. Regarding current trading prices, WXIBF is priced at $3.20, while BXPHF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas BXPHF's P/E ratio is -23.00. In terms of profitability, WXIBF's ROE is +0.06%, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, WXIBF is less volatile compared to BXPHF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs BOVNF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, BOVNF has a market cap of 436.3M. Regarding current trading prices, WXIBF is priced at $3.20, while BOVNF trades at $6.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas BOVNF's P/E ratio is -12.05. In terms of profitability, WXIBF's ROE is +0.06%, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, WXIBF is less volatile compared to BOVNF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs CSPHF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, CSPHF has a market cap of 435.6M. Regarding current trading prices, WXIBF is priced at $3.20, while CSPHF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas CSPHF's P/E ratio is -32.10. In terms of profitability, WXIBF's ROE is +0.06%, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, WXIBF is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs TBGNF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, WXIBF is priced at $3.20, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, WXIBF's ROE is +0.06%, compared to TBGNF's ROE of N/A. Regarding short-term risk, WXIBF and TBGNF have similar daily volatility (0.00).
WXIBF vs CYDY Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, CYDY has a market cap of 431.2M. Regarding current trading prices, WXIBF is priced at $3.20, while CYDY trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas CYDY's P/E ratio is -17.49. In terms of profitability, WXIBF's ROE is +0.06%, compared to CYDY's ROE of +0.07%. Regarding short-term risk, WXIBF is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs HBMHF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, HBMHF has a market cap of 408M. Regarding current trading prices, WXIBF is priced at $3.20, while HBMHF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas HBMHF's P/E ratio is 16.07. In terms of profitability, WXIBF's ROE is +0.06%, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, WXIBF and HBMHF have similar daily volatility (0.00).
WXIBF vs GSGTF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, GSGTF has a market cap of 403.2M. Regarding current trading prices, WXIBF is priced at $3.20, while GSGTF trades at $3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas GSGTF's P/E ratio is -8.16. In terms of profitability, WXIBF's ROE is +0.06%, compared to GSGTF's ROE of +0.78%. Regarding short-term risk, WXIBF is less volatile compared to GSGTF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs PTCHF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, PTCHF has a market cap of 396.3M. Regarding current trading prices, WXIBF is priced at $3.20, while PTCHF trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas PTCHF's P/E ratio is 7.86. In terms of profitability, WXIBF's ROE is +0.06%, compared to PTCHF's ROE of -0.22%. Regarding short-term risk, WXIBF and PTCHF have similar daily volatility (0.00).
WXIBF vs NWBO Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, NWBO has a market cap of 390.9M. Regarding current trading prices, WXIBF is priced at $3.20, while NWBO trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas NWBO's P/E ratio is -4.52. In terms of profitability, WXIBF's ROE is +0.06%, compared to NWBO's ROE of +1.13%. Regarding short-term risk, WXIBF is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs CLVLF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, CLVLF has a market cap of 348.4M. Regarding current trading prices, WXIBF is priced at $3.20, while CLVLF trades at $6.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas CLVLF's P/E ratio is 14.18. In terms of profitability, WXIBF's ROE is +0.06%, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, WXIBF and CLVLF have similar daily volatility (0.00).
WXIBF vs IDRSF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, IDRSF has a market cap of 337.1M. Regarding current trading prices, WXIBF is priced at $3.20, while IDRSF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas IDRSF's P/E ratio is -0.93. In terms of profitability, WXIBF's ROE is +0.06%, compared to IDRSF's ROE of +0.24%. Regarding short-term risk, WXIBF and IDRSF have similar daily volatility (0.00).
WXIBF vs CLVLY Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, CLVLY has a market cap of 323.5M. Regarding current trading prices, WXIBF is priced at $3.20, while CLVLY trades at $6.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas CLVLY's P/E ratio is 13.17. In terms of profitability, WXIBF's ROE is +0.06%, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, WXIBF is less volatile compared to CLVLY. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs HLOSF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, HLOSF has a market cap of 321.6M. Regarding current trading prices, WXIBF is priced at $3.20, while HLOSF trades at $3.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas HLOSF's P/E ratio is -9.91. In terms of profitability, WXIBF's ROE is +0.06%, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, WXIBF and HLOSF have similar daily volatility (0.00).
WXIBF vs PBBIF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, WXIBF is priced at $3.20, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, WXIBF's ROE is +0.06%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, WXIBF is less volatile compared to PBBIF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs PRRUF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, PRRUF has a market cap of 283.3M. Regarding current trading prices, WXIBF is priced at $3.20, while PRRUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas PRRUF's P/E ratio is -9.70. In terms of profitability, WXIBF's ROE is +0.06%, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, WXIBF and PRRUF have similar daily volatility (0.00).
WXIBF vs GNFTF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, GNFTF has a market cap of 276.3M. Regarding current trading prices, WXIBF is priced at $3.20, while GNFTF trades at $5.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas GNFTF's P/E ratio is 13.87. In terms of profitability, WXIBF's ROE is +0.06%, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, WXIBF and GNFTF have similar daily volatility (0.00).
WXIBF vs IPHYF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, IPHYF has a market cap of 267.3M. Regarding current trading prices, WXIBF is priced at $3.20, while IPHYF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas IPHYF's P/E ratio is -4.20. In terms of profitability, WXIBF's ROE is +0.06%, compared to IPHYF's ROE of -1.81%. Regarding short-term risk, WXIBF is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs TRGNF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, TRGNF has a market cap of 263.9M. Regarding current trading prices, WXIBF is priced at $3.20, while TRGNF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas TRGNF's P/E ratio is -6.06. In terms of profitability, WXIBF's ROE is +0.06%, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, WXIBF is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs OPORF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, OPORF has a market cap of 240.5M. Regarding current trading prices, WXIBF is priced at $3.20, while OPORF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas OPORF's P/E ratio is 17.50. In terms of profitability, WXIBF's ROE is +0.06%, compared to OPORF's ROE of +0.42%. Regarding short-term risk, WXIBF and OPORF have similar daily volatility (0.00).
WXIBF vs AVCTF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, AVCTF has a market cap of 239M. Regarding current trading prices, WXIBF is priced at $3.20, while AVCTF trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas AVCTF's P/E ratio is -5.19. In terms of profitability, WXIBF's ROE is +0.06%, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, WXIBF and AVCTF have similar daily volatility (0.00).
WXIBF vs ORYZF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, ORYZF has a market cap of 234.9M. Regarding current trading prices, WXIBF is priced at $3.20, while ORYZF trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas ORYZF's P/E ratio is -43.29. In terms of profitability, WXIBF's ROE is +0.06%, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, WXIBF and ORYZF have similar daily volatility (0.00).
WXIBF vs NWPHF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, NWPHF has a market cap of 231.2M. Regarding current trading prices, WXIBF is priced at $3.20, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas NWPHF's P/E ratio is N/A. In terms of profitability, WXIBF's ROE is +0.06%, compared to NWPHF's ROE of N/A. Regarding short-term risk, WXIBF and NWPHF have similar daily volatility (0.00).
WXIBF vs SLNCF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, SLNCF has a market cap of 225.3M. Regarding current trading prices, WXIBF is priced at $3.20, while SLNCF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas SLNCF's P/E ratio is -3.12. In terms of profitability, WXIBF's ROE is +0.06%, compared to SLNCF's ROE of -0.87%. Regarding short-term risk, WXIBF and SLNCF have similar daily volatility (0.00).
WXIBF vs HNSBF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, HNSBF has a market cap of 223.8M. Regarding current trading prices, WXIBF is priced at $3.20, while HNSBF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas HNSBF's P/E ratio is -2.58. In terms of profitability, WXIBF's ROE is +0.06%, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, WXIBF is less volatile compared to HNSBF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs FPHAF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, WXIBF is priced at $3.20, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, WXIBF's ROE is +0.06%, compared to FPHAF's ROE of N/A. Regarding short-term risk, WXIBF and FPHAF have similar daily volatility (0.00).
WXIBF vs VSBC Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, VSBC has a market cap of 207M. Regarding current trading prices, WXIBF is priced at $3.20, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas VSBC's P/E ratio is N/A. In terms of profitability, WXIBF's ROE is +0.06%, compared to VSBC's ROE of +0.00%. Regarding short-term risk, WXIBF and VSBC have similar daily volatility (0.00).
WXIBF vs FGHQF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, FGHQF has a market cap of 205.6M. Regarding current trading prices, WXIBF is priced at $3.20, while FGHQF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, WXIBF's ROE is +0.06%, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, WXIBF is less volatile compared to FGHQF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs BSEM Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, BSEM has a market cap of 201.2M. Regarding current trading prices, WXIBF is priced at $3.20, while BSEM trades at $12.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas BSEM's P/E ratio is -21.61. In terms of profitability, WXIBF's ROE is +0.06%, compared to BSEM's ROE of +1.50%. Regarding short-term risk, WXIBF is less volatile compared to BSEM. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs AMGXF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, AMGXF has a market cap of 190.7M. Regarding current trading prices, WXIBF is priced at $3.20, while AMGXF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas AMGXF's P/E ratio is -0.69. In terms of profitability, WXIBF's ROE is +0.06%, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, WXIBF is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs CMVLF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, CMVLF has a market cap of 187.4M. Regarding current trading prices, WXIBF is priced at $3.20, while CMVLF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas CMVLF's P/E ratio is -3.88. In terms of profitability, WXIBF's ROE is +0.06%, compared to CMVLF's ROE of -0.30%. Regarding short-term risk, WXIBF is less volatile compared to CMVLF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs SCNLF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, SCNLF has a market cap of 176M. Regarding current trading prices, WXIBF is priced at $3.20, while SCNLF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas SCNLF's P/E ratio is -5.66. In terms of profitability, WXIBF's ROE is +0.06%, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, WXIBF and SCNLF have similar daily volatility (0.00).
WXIBF vs SPHDF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, SPHDF has a market cap of 159M. Regarding current trading prices, WXIBF is priced at $3.20, while SPHDF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas SPHDF's P/E ratio is -3.71. In terms of profitability, WXIBF's ROE is +0.06%, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, WXIBF is less volatile compared to SPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs RECEF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, RECEF has a market cap of 157.2M. Regarding current trading prices, WXIBF is priced at $3.20, while RECEF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas RECEF's P/E ratio is -10.00. In terms of profitability, WXIBF's ROE is +0.06%, compared to RECEF's ROE of +2.26%. Regarding short-term risk, WXIBF is less volatile compared to RECEF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs MLLCF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, MLLCF has a market cap of 155.6M. Regarding current trading prices, WXIBF is priced at $3.20, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas MLLCF's P/E ratio is -2.07. In terms of profitability, WXIBF's ROE is +0.06%, compared to MLLCF's ROE of -0.36%. Regarding short-term risk, WXIBF is less volatile compared to MLLCF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs NGENF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, NGENF has a market cap of 148.5M. Regarding current trading prices, WXIBF is priced at $3.20, while NGENF trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas NGENF's P/E ratio is -7.59. In terms of profitability, WXIBF's ROE is +0.06%, compared to NGENF's ROE of -2.23%. Regarding short-term risk, WXIBF is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs PBIGF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, PBIGF has a market cap of 140.2M. Regarding current trading prices, WXIBF is priced at $3.20, while PBIGF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas PBIGF's P/E ratio is -12.00. In terms of profitability, WXIBF's ROE is +0.06%, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, WXIBF and PBIGF have similar daily volatility (0.00).
WXIBF vs BRIBF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, BRIBF has a market cap of 134.1M. Regarding current trading prices, WXIBF is priced at $3.20, while BRIBF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas BRIBF's P/E ratio is -1.83. In terms of profitability, WXIBF's ROE is +0.06%, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, WXIBF and BRIBF have similar daily volatility (0.00).
WXIBF vs HOFBF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, HOFBF has a market cap of 130.4M. Regarding current trading prices, WXIBF is priced at $3.20, while HOFBF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas HOFBF's P/E ratio is -11.00. In terms of profitability, WXIBF's ROE is +0.06%, compared to HOFBF's ROE of -1.07%. Regarding short-term risk, WXIBF is less volatile compared to HOFBF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs AAPGV Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, WXIBF is priced at $3.20, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas AAPGV's P/E ratio is N/A. In terms of profitability, WXIBF's ROE is +0.06%, compared to AAPGV's ROE of N/A. Regarding short-term risk, WXIBF is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs PRNAF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, PRNAF has a market cap of 126.9M. Regarding current trading prices, WXIBF is priced at $3.20, while PRNAF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas PRNAF's P/E ratio is -1.39. In terms of profitability, WXIBF's ROE is +0.06%, compared to PRNAF's ROE of -1.77%. Regarding short-term risk, WXIBF and PRNAF have similar daily volatility (0.00).
WXIBF vs PSTTF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, WXIBF is priced at $3.20, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, WXIBF's ROE is +0.06%, compared to PSTTF's ROE of N/A. Regarding short-term risk, WXIBF and PSTTF have similar daily volatility (0.00).
WXIBF vs EPRXF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, WXIBF is priced at $3.20, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, WXIBF's ROE is +0.06%, compared to EPRXF's ROE of -0.85%. Regarding short-term risk, WXIBF is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for WXIBF.
WXIBF vs MMIRF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, MMIRF has a market cap of 106.9M. Regarding current trading prices, WXIBF is priced at $3.20, while MMIRF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas MMIRF's P/E ratio is -7.00. In terms of profitability, WXIBF's ROE is +0.06%, compared to MMIRF's ROE of +0.24%. Regarding short-term risk, WXIBF and MMIRF have similar daily volatility (0.00).
WXIBF vs ADOIF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, WXIBF is priced at $3.20, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, WXIBF's ROE is +0.06%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, WXIBF and ADOIF have similar daily volatility (0.00).
WXIBF vs JWCTF Comparison
WXIBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WXIBF stands at 13B. In comparison, JWCTF has a market cap of 101.3M. Regarding current trading prices, WXIBF is priced at $3.20, while JWCTF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WXIBF currently has a P/E ratio of 29.09, whereas JWCTF's P/E ratio is -1.25. In terms of profitability, WXIBF's ROE is +0.06%, compared to JWCTF's ROE of -0.47%. Regarding short-term risk, WXIBF and JWCTF have similar daily volatility (0.00).